Replies to post #41372 on PharmaCyte Biotech Inc (PMCB)

[frosr6]

Guess what? Nothing new nothing different than from 1998. Why does pmcb feel the need to manipulate words to sell their stock?

Quote:
"PharmaCyte Biotech Inc. (OTCMKTS:PMCB), however, may be close to tapping into the potential of live-cell encapsulation by using a different, more durable and more effective "shell" for its capsules. "

See>>
http://www.nature.com/gt/journal/v5/n8/pdf/3300671a.pdf

1998
Cells that have been genetically modified to express the cytochrome P450 2B1 enzyme are encapsulated in cellulose sulphate and implanted into pre-established tumours derived from human pancreatic cells. Cytochrome P450 2B1 converts the chemotherapeutic agent ifosfamide to toxic metabolites. Administration of ifosfamide to tumour-bearing mice that were recipients of implanted encapsulated cells results in partial or even com- plete tumour ablation. These results suggest that in situ chemotherapy with genetically modified cells in an immunoprotected environment may prove useful for application in man.